Atlas maps trawling in the Mediterranean – General news


(ANSAmed) – ROME, 02 NOV – “Atlas” is a report which “for the first time” maps the areas definitively closed to trawling in the Mediterranean and investigates these activities in the area.

Atlas (, published ahead of the annual session of the General Commission for Mediterranean Fisheries (Cgpm), to be held in Tirana, Albania, from 7 to 11 November, shows the and confirmed violations of trawling in protected areas where it is permanently prohibited. It was presented by members of the Med Sea Alliance, a movement created in 2020 to bring together NGOs and other civil society groups working to improve the health and productivity of the Mediterranean Sea.

Atlas shows over 350 areas of the Mediterranean permanently closed to trawling, mapped by MedReAct and uses data, algorithms and models developed by Global Fishing Watch to assess potential violations. During the period January 2020 to January 2021, Atlas documented data from Global Fishing Watch, alleged trawling activity in 35 protected areas in the Mediterranean, by some 305 fishing vessels, for a total of 9,518 fishing days. suspected fishing. Atlas also illustrates, based on research conducted by MedReAct on data reported by the media and the national control authorities of Italy, France, Spain, Turkey, Egypt, Tunisia, Algeria and Morocco, some 170 cases of infringements confirmed between January 2018 and December 2020 concerning Italy, Turkey, France, Algeria and Morocco. Included in the overall figure are infringements concerning Italy, “the only country in Europe that provided clear data and which between January 2018 and June 2021 registered 85 sanctioned infringements, 80 of them in areas where fishing was restricted , set up by the Cgpm and five in protected areas”. marine areas”. For alleged infringements in 178 Italian areas closed to trawling, the analysis carried out by Atlas highlighted possible illegal fishing activities in 14 areas protected by presumably 114 fishing vessels from 2020 to 2021. (ANSAmed)


About Author

Comments are closed.